IMA vs ROP · rev $9.2M vs P/E 41, rev $1.88B
ImageneBio, Inc. (IMA) versus Roper Technologies, Inc. (ROP) — a side-by-side from cached financials, not a winner call.
ImageneBio, Inc. (IMA) is a biotechnology company listed on NASDAQ.
Roper Technologies, Inc. (ROP) is a software - application company listed on US.
Latest reported IMA revenue for 2023-12-31 was $9.2M. Net income was -$68.2M. Revenue was down 41.3% from 2022-12-31 to 2023-12-31. IMA currently screens at market cap $64.7M.
Latest reported ROP revenue for 2024-12-31 was $1.88B. Net income was $462.3M. Revenue was up 6.4% from 2024-09-30 to 2024-12-31. ROP currently screens at market cap $61.61B and trailing P/E 41.3.
IMA currently screens at market cap $64.7M. ROP currently screens at market cap $61.61B and trailing P/E 41.3.
Not investment advice. Open the IMA and ROP stock pages for the full models.
Not investment advice.